- Home
- ARQT vs SPNS Comparison
ARQT vs SPNS Comparison
Compare ARQT & SPNS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ARQT
- SPNS
- Stock Information
- Founded
- ARQT 2016
- SPNS 1982
- Country
- ARQT United States
- SPNS Israel
- Employees
- ARQT N/A
- SPNS N/A
- Industry
- ARQT Biotechnology: Pharmaceutical Preparations
- SPNS Computer Software: Prepackaged Software
- Sector
- ARQT Health Care
- SPNS Technology
- Exchange
- ARQT Nasdaq
- SPNS Nasdaq
- Market Cap
- ARQT 1.7B
- SPNS 1.6B
- IPO Year
- ARQT 2020
- SPNS 1992
- Fundamental
- Price
- ARQT $15.76
- SPNS $29.71
- Analyst Decision
- ARQT Strong Buy
- SPNS Buy
- Analyst Count
- ARQT 6
- SPNS 4
- Target Price
- ARQT $18.80
- SPNS $34.25
- AVG Volume (30 Days)
- ARQT 2.0M
- SPNS 161.4K
- Earning Date
- ARQT 08-13-2025
- SPNS 07-31-2025
- Dividend Yield
- ARQT N/A
- SPNS 2.03%
- EPS Growth
- ARQT N/A
- SPNS 11.11
- EPS
- ARQT N/A
- SPNS 1.30
- Revenue
- ARQT $212,819,000.00
- SPNS $544,235,000.00
- Revenue This Year
- ARQT $61.01
- SPNS $8.30
- Revenue Next Year
- ARQT $37.95
- SPNS $7.42
- P/E Ratio
- ARQT N/A
- SPNS $22.70
- Revenue Growth
- ARQT 100.03
- SPNS 3.84
- 52 Week Low
- ARQT $7.86
- SPNS $23.69
- 52 Week High
- ARQT $17.75
- SPNS $41.22
- Technical
- Relative Strength Index (RSI)
- ARQT 60.23
- SPNS 55.31
- Support Level
- ARQT $13.06
- SPNS $29.50
- Resistance Level
- ARQT $15.36
- SPNS $30.54
- Average True Range (ATR)
- ARQT 0.66
- SPNS 0.48
- MACD
- ARQT 0.12
- SPNS 0.02
- Stochastic Oscillator
- ARQT 82.57
- SPNS 60.48
About ARQT Arcutis Biotherapeutics Inc.
Arcutis Biotherapeutics Inc is a medical dermatology company. It is developing treatments for patients with immune-mediated dermatological diseases and conditions. It is leveraging recent advances in immunology and inflammation to develop differentiated therapies against biologically validated targets to solve persistent treatment challenges in serious diseases of the skin. The company's product candidate ZORYVE roflumilast cream, has completed pivotal Phase 3 clinical trials in plaque psoriasis, demonstrating symptomatic improvement and favorable tolerability in this population.
About SPNS Sapiens International Corporation N.V. (Cayman Islands)
Sapiens International Corp NV is a provider of software solutions for the insurance industry, with an emerging focus on the financial services sector. The company offers software, solutions, and professional services for property & casualty (P&C); reinsurance; life, pension & annuity (L&A); workers' compensation (WC); medical professional liability (MPL); financial & compliance (F&C); and decision modeling for both insurance and financial markets. The group also provides services for project delivery and implementation services, for its Software Solutions portfolio. Geographically, it operates in the region of North America, Rest of the World, and Europe. It generates revenue from Europe.